切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2019, Vol. 13 ›› Issue (03) : 182 -186. doi: 10.3877/cma.j.issn.1674-0807.2019.03.010

所属专题: 文献

综述

乳腺癌寡转移的局部治疗进展
竺美珍1, 俞洋1,(), 杨红健1   
  1. 1. 310022 杭州,浙江省肿瘤医院乳腺外科
  • 收稿日期:2017-03-09 出版日期:2019-06-01
  • 通信作者: 俞洋
  • 基金资助:
    浙江省卫生厅科研基金资助项目(2012KYB037)

Local treatment for oligometastatic breast cancer

Meizhen Zhu1, Yang Yu1(), Hongjian Yang1   

  • Received:2017-03-09 Published:2019-06-01
  • Corresponding author: Yang Yu
引用本文:

竺美珍, 俞洋, 杨红健. 乳腺癌寡转移的局部治疗进展[J/OL]. 中华乳腺病杂志(电子版), 2019, 13(03): 182-186.

Meizhen Zhu, Yang Yu, Hongjian Yang. Local treatment for oligometastatic breast cancer[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2019, 13(03): 182-186.

乳腺癌是女性常见的恶性肿瘤,经过综合治疗后,有近30%患者会发生远处转移,转移性乳腺癌治疗棘手,预后差。如果远处转移灶的数目和大小都较局限,且处于低负荷肿瘤转移状态,不具备全身广泛转移的潜能,可能通过局部治疗达到完全缓解的转移病灶称为寡转移。对这部分寡转移的乳腺癌患者,治疗方式与全身广泛转移者不同,手术或放射治疗等局部治疗可能达到完全缓解。笔者就乳腺癌寡转移及常见寡转移器官的局部治疗进展进行综述。

表1 乳腺癌肺寡转移的相关临床研究
表2 乳腺癌肝寡转移的相关临床研究
[1]
Jemal A,Siegel R,Ward E,et al.Cancer statistics,2018 [J]. CA Cancer J Clin, 2008, 58 (2):71-96.
[2]
Redig AJ, McAllister SS. Breast cancer as a systemic disease: a view of metastasis[J]. J Intern Med, 2013, 274(2): 113-126.
[3]
Bartlett EK,Simmons KD, Wachtel H,et al. The rise in metastasectomy across cancer types over the past decade [J]. Cancer,2015,121(5):747-757.
[4]
徐兵河,江泽飞,胡夕春.中国晚期乳腺癌临床诊疗专家共识2016[J]. 中华医学杂志,2016, 96(22):1719-1727.
[5]
National Comprehensive Cancer Network. The NCCN breast cancer clinical practice guidelines in oncology (version 2.2018) [EB/OL]. [2018-10-05].

URL    
[6]
Cardoso F, Costa A, Norton L,et al. ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)[J]. Breast,2014, 23(5):489-502.
[7]
Hellman S, Weichselbaum RR. Oligometastases[J]. J Clin Oncol, 1995, 13(1):8-10.
[8]
Weichselbaum RR,Hellman S. Oligometastases revisited [J]. Nat Rev Clin Oncol,2011,8(6):378-382.
[9]
Cardoso F, Costa A, Senkus E,et al. 3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3) [J]. Ann Oncol, 2017, 28(12):3111.
[10]
Drazer MW, Salama JK, Hahn OM,et al. Stereotactic body radiotherapy for oligometastatic breast cancer: a new standard of care, or a medical reversal in waiting ? [J]. Expert Rev Anticancer Ther, 2016, 16(6):625-632.
[11]
Jain SK, Dorn PL, Chmura SJ,et al. Incidence and implications of oligometastatic breast cancer [J]. J Clin Oncol, 2012,30 Suppl: e11512.
[12]
Lussier YA,Xing HR,Salama JK,et al. MicroRNA expression characterizes oligometastasis(es) [J]. PLoS One,2011,6(12):e28650.
[13]
Uppal A, Wightman SC, Mallon S,et al. 14q32-encoded microRNAs mediate an oligometastatic phenotype [J]. Oncotarget, 2015, 6(6):3540-3552.
[14]
Khan SA,Stewart AK,Morow M. Does aggressive local therapy improve survival in metastatic breast cancer? [J]. Surgery, 2002, 132(4):620-626.
[15]
Rayter Z. Surgery for stage Ⅳ breast cancer [J]. Eur J Surg Oncol, 2012, 38(5):432.
[16]
Soran A, Ozmen V, Ozbas S, et al. Randomized trial comparing resection of primary tumor with no surgery in stage Ⅳ breast cancer at presentation: protocol MF07-01[J].Ann Surg Oncol, 2018, 25(11):3141-3149.
[17]
King TA, Lyman JP, Gonen M, et al. A prospective analysis of surgery and survival in stage Ⅳ breast cancer (TBCRC 013) [C/OL]// Translational Breast Cancer Research Consortium: 2016 ASCO Annual Meeting, Chicago,2016[2017-03-01].

URL    
[18]
Badwe R, Hawaldar R, Nair N, et al. Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial[J]. Lancet Oncol,2015,16(13): 1380-1388.
[19]
Akay CL, Ueno NT, Chisholm GB,et al. Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage Ⅳ inflammatory breast cancer [J]. Cancer,2014,120(9):1319-1328.
[20]
Tait CR, Waterworth A, Loncaster J,et al. The oligometastatic state in breast cancer:hypothesis or reality[J]. Breast,2005,14(2):87-93.
[21]
Niwinska A,Pogoda K,Murawska M,et al. Factors influencing survival in patients with breast cancer and single or solitary brain metastasis [J]. Eur J Surg Oncol, 2011, 37(7):635-642.
[22]
马莉,王慧,余春华,等. 乳腺癌脑转移研究进展[J/CD]. 中华乳腺病杂志(电子版),2015,9(3):192-197.
[23]
Chidel MA,Suh JH,Reddy CA,et al. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases [J]. Int J Radiat Oncol Biol Phys, 2000, 47(4):993-999.
[24]
Robins HI, O’Neill A, Mehta M, et al. A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT & SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320: in regard to Sperduto et al[J]. Int J Radiat Oncol Biol Phys, 2013, 86(5):809-810.
[25]
Staren ED,Salerno C,Rongione A, et al. Pulmonary resection for metastatic breast cancer [J]. Arch Surg,1992,127(11):1282-1284.
[26]
Lanza LA, Natarajan G, Roth JA, et al. Long-term survival after resection of pulmonary metastases from carcinoma of the breast[J]. Ann Thorac Surg, 1992, 54(2):244-247.
[27]
Pastorino U, Buyse M, Friedel G, et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases[J]. J Thorac Cardiovasc Surg,1997,113(1):37-49.
[28]
Yoshimoto M,Tada K,Nishimura S,et al. Favourable long-term results after surgical removal of lung metastases of breast cancer[J]. Breast Cancer Res Treat,2008,110(3):485-491.
[29]
Chen F,Fujinaga T,Sato K. Clinical features of surgical resection for pulmonary metastasis from breast cancer [J]. Eur J Surg Oncol,2009,35(4):393-397.
[30]
袁芃,徐兵河,张频,等. 21例乳腺癌术后孤立性肺转移的临床分析及预后[J].中国肿瘤临床,2010,37(12):698-700,709.
[31]
Wyld L,Gutteridge E,Pinder SE,et al. Prognostic factors for patients with hepatic metastases from breast cancer[J]. Br J Cancer,2003,89(2):284-290.
[32]
钱杨,王健,曾昭冲. 结直肠癌肝转移的治疗进展[J/CD].中华结直肠疾病电子杂志,2016,5(1):16-20.
[33]
Pocard M,Pouillart P,Asselain B, et al. Hepatic resection for breast cancer metastases: results and prognosis (65 cases) [J]. Ann Chir, 2001, 126(5):413-20.
[34]
Abbott DE, Brouquet A, Mittendorf EA,et al. Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy before metastasectomy define outcome[J]. Surgery,2012,151(5):710-716.
[35]
Kim JY, Park JS, Lee SA. Does liver resection provide long-term survival benefits for breast cancer patients with liver metastasis? A single hospital experience[J].Yonsei Med J, 2014, 55(3):558-562.
[36]
Bacalbasa N, Dima SO, Purtan-Purnichescu R,et al. Role of surgical treatment in breast cancer liver metastases: a single center experience[J]. Anticancer Res, 2014, 34(10):5563-5568.
[37]
Margonis GA, Buettner S, Sasaki K,et al. The role of liver-directed surgery in patients with hepatic metastasis from primary breast cancer:a multi-institutional analysis[J]. HPB(Oxford), 2016, 18(8):700-705.
[38]
Seidensticker M, Garlipp B, Scholz S,et al. Locally ablative treatment of breast cancer liver metastases: identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study) [J]. BMC Cancer, 2015, 15:517.
[39]
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials[J]. Lancet,2005,365(9472):1687-1717.
[40]
Coleman RE,Smith P,Rubens RD. Clinical course and prognostic factors following bone recurrence from breast cancer [J]. Br J Cancer,1998,77(2):336-340.
[41]
胡群超,俞晓立,郭小毛. 放射治疗在乳腺癌骨转移中的临床应用进展[J].中国癌症杂志,2016,26(4):346-350.
[42]
Durr HR,Muller PE,Lenz T,et al. Surgical treatment of bone metastases in patients with breast cancer[J]. Clin Orthop Relat Res,2002(396):191-196.
[43]
Hosaka S, Katagiri H, Honda Y,et al. Clinical outcome for patients of solitary bone only metastasis[J]. J Orthop Sci,2016,21(2):226-229.
[44]
Noguchi S, Miyauchi K, Nishizawa Y,et al. Results of surgical treatment for sternal metastases of breast cancer[J]. Cancer, 1988, 62(7):1397-1401.
[45]
Kang HJ, Lee SA, Park KS,et al. Simultaneous chest wall reconstruction after sternectomy and modified radical mastectomy in locally advanced breast cancer with solitary sternal metastasis [J]. J Breast Cancer, 2012,15(4):462-467.
[46]
Rosenberg M, Castagno A, Nadal J,et al. Sternal metastasis of breast cancer: ex vivo hypothermia and reimplantation [J]. Ann Thorac Surg,2011,91(2):584-586.
[47]
Demondion P, Mercier O, Kolb F,et al. Sternal replacement with a custom-made titanium plate after resection of a solitary breast cancer metastasis [J]. Interact Cardiovasc Thorac Surg,2014,18(1):145-147.
[48]
Lam KY, Lo CY. Metastatic tumours of the adrenal glands: a 30-year experience in a teaching hospital[J]. Clin Endocrinol (Oxf),2002,56(1):95-101.
[49]
Kim SH,Brennan MF,Russo P,et al. The role of surgery in the treatment of clinically isolated adrenal metastasis [J]. Cancer,1998,82(2):389-394.
[50]
Lee JY, Kang HW, Jung SN. Solitary gluteus maximus muscle metastasis in a breast cancer patient [J]. Arch Plast Surg,2015,42(5):661-663.
[51]
Maekawa H, Fujikawa T, Tanaka A. Successful laparoscopic investigation and resection of solitary colonic metastasis from breast cancer (with video)[EB/OL].[2017-03-01].

URL    
[1] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[2] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[3] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[4] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[5] 李友, 唐林峰, 杜伟伟, 刘海亮, 余新水, 沈佳宇, 巨积辉. 皮瓣联合掌长肌腱折叠单排三点式固定治疗指背侧创面伴锤状指畸形的临床效果观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 485-490.
[6] 刘敏, 唐恩溢, 刘喆, 葛苏蒙, 刘梅, 孙国文. 计算机导航技术在口腔颌面部微小异物取出手术中的应用[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(06): 375-379.
[7] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[8] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[9] 孙莲, 马红萍, 吴文英. 局部进展期甲状腺癌患者外科处理[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 112-114.
[10] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[11] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[12] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
[13] 陈宗杰, 胡添松. 肝外伤破裂患者治疗后胆漏发生影响因素分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 836-840.
[14] 张润锦, 阳盼, 林燕斯, 刘尊龙, 刘建平, 金小岩. EB病毒相关胆管癌伴多发转移一例及国内文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 865-869.
[15] 刘卓, 张宗明, 张翀, 刘立民, 赵月, 齐晖. 腹腔镜手术治疗高龄急性梗阻性化脓性胆管炎患者的安全性与术式选择[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 795-800.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?